Business

Eisai is applying for full FDA approval for Reuters’ Alzheimer’s drug Leqembi

Eisai is applying for full FDA approval for Reuters’ Alzheimer’s drug Leqembi

#Eisai #applying #full #FDA #approval #Reuters #Alzheimers #drug #Leqembi Welcome to Alaska Green Light Blog, here is the new story we have for you today:

Click Me To View Restricted Videos


©Reuters. FILE PHOTO: The Eisai Co Ltd logo is displayed on March 8, 2018 at the company’s headquarters in Tokyo, Japan. REUTERS/Issei Kato/File Photo

(Reuters) – Japanese drugmaker Eisai Co (OTC:) Ltd said on Saturday it had submitted an application to the US Food and Drug Administration for a standard review of its Alzheimer’s drug Leqembi, which was recently submitted under the agency’s expedited review process was approved.

Click Here To Continue Reading From Source

Related Articles

Back to top button